[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351658-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-351658-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","subtype-independent-activation-of-nf-b-signaling-in-breast-cancer","Subtype-Independent Activation of NF-κB Signaling in Breast Cancer","","Nuclear factor kappa B (NF-κB) signaling is central to inflammation, immunity, cell survival, and cancer progression, and constitutive activation is commonly observed in breast cancer. The study aims to identify microRNAs (miRNAs) that may regulate NF-κB-associated genes across five molecular subtypes in Polish women. Tumor and matched normal samples from 405 patients were analyzed using mRNA microarrays and RT-qPCR, protein assessment by ELISA, and miRNA validation using miRDB. Results showed consistent upregulation of multiple NF-κB components across subtypes and downregulation of selected miRNAs that may drive altered gene expression.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/subtype-independent-activation-of-nf-b-signaling-in-breast-cancer/351658/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/subtype-independent-activation-of-nf-b-signaling-in-breast-cancer/351658.png","ImageObject",300,407,{"name":42,"@type":43},"Cipher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What was the main objective of the study?","Question",{"text":62,"@type":63},"To identify miRNAs that may potentially regulate NF-κB signaling–related gene activity across five molecular subtypes of breast cancer in Polish women.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"How were tumor and gene expression data analyzed?",{"text":67,"@type":63},"Expression profiles of NF-κB-related genes were evaluated using mRNA microarrays and RT-qPCR, protein levels were measured by ELISA, and candidate miRNAs were identified from miRNA microarrays and validated with miRDB.",{"name":69,"@type":60,"acceptedAnswer":70},"What key findings support subtype-independent NF-κB activation?",{"text":71,"@type":63},"A consistent upregulation of multiple NF-κB-related components (including MAP3K7, TAB2, TNFAIP3, CSNK2A1, and others) was observed across all subtypes, along with specific miRNA downregulation likely contributing to deregulation.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},351658,1790133393,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Article  \nSubtype-Independent Activation of NF-κB Signaling in Breast Cancer  \nElbieta Mitka-Krysiak 1,*, Katarzyna Król-Jatr˛ega 1, Piotr Ossowski 1, Nikola Zmarzły 1, Krzysztof Bereza 2, Paweł Ordon 1, Tomasz Sirek 1,3,4, Agata Sirek 1, Kacper Boro ´n 3, Dariusz Boro ´n 1,5,6,7,8, Grzegorz Wyrobiec 9, Tomasz Szczepanik 1, Marta Skorek 1 and Beniamin Oskar Grabarek 1  \nAcademic Editor: Anna Makuch-Kocka  \nReceived: 30 March 2026  \nRevised: 26 April 2026  \nAccepted: 29 April 2026  \nPublished: 30 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Collegium Medicum, WSB University, 41-300 Dabrowa Gornicza, Poland;  \n[katarzynakroljatrenga@gmail.com](katarzynakroljatrenga@gmail.com) (K.K.-J.); [drpiotrossowski15@gmail.com](drpiotrossowski15@gmail.com) (P.O.);  \n[nikola.zmarzly@gmail.com](nikola.zmarzly@gmail.com) (N.Z.); [pawelordon4@gmail.com](pawelordon4@gmail.com) (P.O.); [drtstierka@gmail.com](drtstierka@gmail.com) (T.S.);  \n[agatasirek06@gmail.com](agatasirek06@gmail.com) (A.S.); [dariusz@boron.pl](dariusz@boron.pl) (D.B.); [tomekdok@o2.pl](tomekdok@o2.pl) (T.S.); [mskorek@wsb.edu.pl](mskorek@wsb.edu.pl) (M.S.); [bgrabarek7@gmail.com](bgrabarek7@gmail.com) (B.O.G.)  \n2 Department of Mother and Child Health, Faculty of Health Sciences, Institute of Nursing and Midwifery, Jagiellonian University Medical College, 31-008 Kraków, Poland; [kbereza@su.krakow.pl](kbereza@su.krakow.pl)  \n3 Department of Plastic Surgery, Faculty of Medicine, Academia of Silesia, 40-555 Katowice, Poland; [q374@gmail.com](q374@gmail.com)  \n4 Department of Plastic and Reconstructive Surgery, Hospital for Minimally Invasive and Reconstructive Surgery in Bielsko-Biała, 43-316 Bielsko-Biala, Poland  \n5 Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University in Kraków, 30-705 Kraków, Poland  \n6 Department of Gynecology and Obstetrics, TOMMED Specjalisci od Zdrowia, 40-055 Katowice, Poland  \n7 Department of Gynecology and Obstetrics with Gynecologic Oncology, Ludwik Rydygier Memorial Specialized Hospital, 31-826 Kraków, Poland  \n8 Faculty of Medicine, VIZJA University, 01-043 Warsaw, Poland  \n9 Department of Histology and Cell Pathology in Zabrze, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, 41-808 Zabrze, Poland; [gwyrobiec@sum.edu.pl](gwyrobiec@sum.edu.pl)  \n* Correspondence: [elzbietamitkakrysiak@gmail.com](elzbietamitkakrysiak@gmail.com)  \nAbstract  \nNuclear factor kappa B (NF-κB) signaling plays a central role in inflammation, immunity, cell survival, and cancer progression. Its constitutive activation is frequently observed in breast cancer, contributing to tumor growth, treatment resistance, and metastasis. MicroRNAs (miRNAs) are key post-transcriptional regulators of gene expression and may modulate NF-κB signaling in a subtype-specific or-independent manner. The aim of the study was to identify miRNAs that may potentially regulate the activity of genes associated with NF-κB signaling across five molecular subtypes of breast cancer in Polish women. Tumor and matched normal tissue samples were collected from 405 patients with five breast cancer subtypes: luminal A (n = 130), HER2-negative luminal B (n = 100), HER2-positive luminal B (n = 96), non-luminal HER2-positive (n = 36), and triple-negative breast cancer (TNBC, n = 43) . Expression profile of selected NF-κB-related genes were evaluated using mRNA microarrays and RT-qPCR. Protein levels were assessed by ELISA. Candidate regulatory miRNAs were identified via miRNA microarrays and validated using the miRDB database. A consistent upregulation of MAP3K7, TAB2, TNFAIP3, CSNK2A1, BCL2L1, XIAP, CXCL2, and PLAU was observed across all subtypes, suggesting activation of canonical NF-κB signaling. Downregulation of specific miRNAs, miR-1297 and miR-30a (targeting MAP3K7), miR-134 (T","cbCaioSwI0gyYKzz","https://ap.wps.com/l/cbCaioSwI0gyYKzz","pdf",2322571,21,"English","# Abstract\n## Introduction","[{\"question\":\"What was the main objective of the study?\",\"answer\":\"To identify miRNAs that may potentially regulate NF-κB signaling–related gene activity across five molecular subtypes of breast cancer in Polish women.\"},{\"question\":\"How were tumor and gene expression data analyzed?\",\"answer\":\"Expression profiles of NF-κB-related genes were evaluated using mRNA microarrays and RT-qPCR, protein levels were measured by ELISA, and candidate miRNAs were identified from miRNA microarrays and validated with miRDB.\"},{\"question\":\"What key findings support subtype-independent NF-κB activation?\",\"answer\":\"A consistent upregulation of multiple NF-κB-related components (including MAP3K7, TAB2, TNFAIP3, CSNK2A1, and others) was observed across all subtypes, along with specific miRNA downregulation likely contributing to deregulation.\"}]","Subtype-Independent Activation of NF-κB Signaling in Breast Cancer | PDF",1790095153,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b6ef28b453fbc1818c08bad77bb047b.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d23707770774b20cc039a762d1cd66b9.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da5343c2c5debeeeb8e96f3275aeacde.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c96ba800c574d3c50c4295e9f4afc7b2.webp",980,1385]